Pharmacy Report Archives - Page 23 of 136 - Becker's Hospital Review

Hospital Rx safety advances: Leapfrog | 340B rebate challenges, explained | AI in hospital pharmacy: 4 execs | New drug ad rules take effect: 4 notes | 3 IV fluid shortage updates

November 18, 2024 BHR Newsletter 1. Drugmakers' 340B rebate fight, explained Full story 2. Pharmacy leaders explore AI's potential Full story 3. What's driving hospitals' medication safety advances? Full story 4. Ardent Health and MemorialCare are simplifying purchased services —…

The financial cost of drug shortages: Case study | FDA inspectors in short supply | 10 systems seeking pharmacy leaders | FDA rejects full approval of liver disease drug | Mounjaro helps 99% of prediabetes patients: Study

November 14, 2024 BHR Newsletter 1. FDA struggles to retain inspectors: GAO Full story 2. Mounjaro lowers Type 2 diabetes risk in phase 3 trial: Study Full story 3. The financial burden of drug shortages: 7 study takeaways Full story…

J&J renews push for 340B rebates | What retail pharmacy closures mean for hospitals | Kaiser posts $608M Q3 loss, cites high pharmacy costs | Inova cuts daily IV fluid use in half | Pros, cons to ambulatory pharmacies

November 13, 2024 BHR Newsletter 1. What retail pharmacy closures spell for healthcare Full story 2. J&J sues government over 340B rebate plan Full story 3. Hospital operator plans to sell 10 of 16 hospitals Full story 4. Pharmacy-HR collaboration…

9 new drug shortages | 2024's biggest wins, per 5 hospital pharmacy execs | Clinical hold ends for combo flu, COVID vaccine trial | Mich. pharmacist convicted in $15M case | Wis. system CEO to step down

November 12, 2024 BHR Newsletter 1. Pharmacy leaders highlight 2024's top achievements Full story 2. 9 drugs now in shortage Full story 3. FDA lifts clinical hold on combined COVID-19-influenza vaccine trials Full story 4. Large academic medical center boosts…

U of Calif. pharmacy workers to strike | Pharmacy directors, techs in high demand | Cleveland Clinic's cancer vaccine shows promise | 3 Ozempic updates | ASHP taps pharmacy leadership VP

November 11, 2024 BHR Newsletter 1. Breast cancer vaccine produces immune response: Cleveland Clinic Full story 2. Half of US hospitals have enough IV fluids for 2 weeks Full story 3. Pharmacy directors, techs in high demand Full story 4.…

FDA weighs pulling common decongestant | New warning added to GLP-1 labels | Calif. might restrict 340B spending | 10 systems seeking pharmacy leaders | Pharmacists sue La. over abortion pill classification

November 7, 2024 BHR Newsletter 1. FDA proposes pulling common decongestant from shelves Full story 2. Compounded Ozempic tied to deaths, hospitalizations: Novo Nordisk CEO Full story 3. 340B spending restrictions on track for passage in California Full story 4.…

Gene therapy trial reports death | More IV fluids at risk | Trump's win: 7 healthcare notes | Tenn. pharmacy owners charged in fraud case | Ozempic improves liver disease: Study

November 6, 2024 BHR Newsletter 1. Sickle cell patient dies in gene-therapy trial Full story 2. APhA calls for action amid pharmacy closures: 3 notes Full story 3. Storm could threaten IV supplies on Gulf Coast: 3 things to know…

Walgreens settles 2 cases for $206M | IV fluid supply to stabilize soon: AHA expert | Study ties low-dose aspirin to anemia in older adults | 5 healthcare ballot measures | 50% of drug shortages last 2+ years

November 5, 2024 BHR Newsletter 1. Walgreens pays $100M to settle overcharging allegations, $106M to settle false billing claims Full story 2. Low-dose aspirin linked to anemia increase in older adults: Study Full story 3. 50% of US drug shortages…

Idaho county limits COVID shot access | Wegovy cuts admissions, LOS | 2 drugmakers pay $49M to settle case | Demand dips for hospital pharmacists | NJ system files for bankruptcy

November 4, 2024 BHR Newsletter 1. COVID vaccine removed from Idaho district county health clinics: 5 things to know Full story 2. Wegovy reduces all-cause admissions: 3 study findings Full story 3. Demand for hospital pharmacists dips Full story 4.…

Baxter restarts NC site: 5 updates | 1st system achieves ASHP's excellence status | 10 systems seeking pharmacy leaders | Novant debuts specialty, infusion pharmacy co. | $5.54 v. $54 for 1 Rx: How PBMs favor big chains

October 31, 2024 BHR Newsletter 1. 1st multisite system achieves ASHP's center of excellence designation Full story 2. FDA grants accelerated approval for leukemia treatment Full story 3. Baxter restarts highest throughput line: 5 shortage updates Full story 4. Your EHR…